Innovations for Changing the Face of Women’s Reproductive Health Therapeutics

At ObsEva, our passion and expertise in reproductive health and pregnancy therapeutics is helping millions of women worldwide lead healthier and more fulfilling lives.

Significant Unmet Needs in Reproductive Health

Millions of women worldwide suffer from reproductive health conditions that affect their quality of life or ability to conceive and may lead to complications during pregnancy.

Innovation From Conception to Birth and Beyond

ObsEva is advancing a robust pipeline of novel, orally-administered, clinical-stage compounds in the areas of uterine fibroids, endometriosis, assisted reproductive technology, and preterm labor.

Recent Updates

25 Apr 2017

ObsEva SA Initiates Phase 3 Clinical Program for OBE2109 in Uterine Fibroids

Read More
24 Mar 2017

ObsEva SA to Attend Needham Annual Healthcare Conference in NYC

Read More
17 Mar 2017

ObsEva to Present Pharmacology Results Demonstrating OBE022 Exerts a Synergistic Effect in Combination with Standard of Care in Animal Model for Preterm Labor

Read More
07 Mar 2017

ObsEva Starts Phase 3 Clinical Program for Nolasiban in ART

Read More